Onconova Therapeutics Announces Publication of Preclinical Data Supporting Rigosertib's Mechanism of Action as a Targeted Anticancer Therapy Nasdaq:ONTX

Press/Media

Period23 Jul 2020

Media coverage

12

Media coverage